GEODE CAPITAL MANAGEMENT, LLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GEODE CAPITAL MANAGEMENT, LLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q4 2021$732,000
+46.4%
53,740
+75.8%
0.00%
Q3 2021$500,000
-27.0%
30,564
-25.0%
0.00%
Q2 2021$685,000
-48.6%
40,757
-44.1%
0.00%
Q1 2021$1,332,000
+111.1%
72,961
+110.2%
0.00%
Q4 2020$631,000
-30.1%
34,703
-31.5%
0.00%
Q3 2020$903,000
+3.4%
50,634
+3.9%
0.00%
Q2 2020$873,000
+80.7%
48,742
+53.0%
0.00%
Q1 2020$483,000
-80.6%
31,865
-74.7%
0.00%
Q4 2019$2,484,000
+212.5%
125,948
+172.2%
0.00%
Q3 2019$795,000
+18.1%
46,264
+21.7%
0.00%
Q2 2019$673,000
-58.1%
38,026
-51.9%
0.00%
Q1 2019$1,608,000
+1.1%
78,995
-16.5%
0.00%
Q4 2018$1,590,00094,6460.00%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Bartlett & Co. LLC 20,781$2960.01%
Valued Wealth Advisors LLC 231$3,5740.00%
BALDWIN BROTHERS LLC/MA 2,035$29,0390.00%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders